ALENO Fundamental Analysis - ENOGIA SAS

Fundamental Rating

Taking everything into account, ALENO scores 3 out of 10 in our fundamental rating. ALENO was compared to 68 industry peers in the Electrical Equipment industry. ALENO has a bad profitability rating. Also its financial health evaluation is rather negative. ALENO is not overvalued while it is showing excellent growth. This is an interesting combination.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALENO had negative earnings in the past year.

ALENO had negative earnings in each of the past 5 years.

In the past 5 years ALENO always reported negative operating cash flow.

1.2 Ratios

ALENO has a Return On Assets (-1.98%) which is in line with its industry peers.

ALENO has a Return On Equity (-5.59%) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-1.98%
ROE	-5.59%
ROIC	N/A

ROA(3y)-15.16%

ROA(5y)-16.28%

ROE(3y)-43.3%

ROE(5y)-107.28%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 114.85%, ALENO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

ALENO's Gross Margin has declined in the last couple of years.

ALENO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	114.85%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.11%

GM growth 5Y-12.18%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALENO does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALENO remains at a similar level compared to 1 year ago.

Compared to 5 years ago, ALENO has more shares outstanding

The debt/assets ratio for ALENO is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.54, we must say that ALENO is in the distress zone and has some risk of bankruptcy.

ALENO has a Altman-Z score of 1.54. This is comparable to the rest of the industry: ALENO outperforms 44.12% of its industry peers.

A Debt/Equity ratio of 0.80 indicates that ALENO is somewhat dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.80, ALENO is doing worse than 67.65% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.8
Debt/FCF	N/A
Altman-Z	1.54

ROIC/WACCN/A

WACC7.88%

2.3 Liquidity

A Current Ratio of 1.82 indicates that ALENO should not have too much problems paying its short term obligations.

Looking at the Current ratio, with a value of 1.82, ALENO is in the better half of the industry, outperforming 67.65% of the companies in the same industry.

ALENO has a Quick Ratio of 1.80. This is a normal value and indicates that ALENO is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.80, ALENO belongs to the top of the industry, outperforming 85.29% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.82
Quick Ratio	1.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALENO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.50%, which is quite impressive.

Looking at the last year, ALENO shows a very strong growth in Revenue. The Revenue has grown by 55.69%.

The Revenue has been growing by 25.85% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)59.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%107.01%

Revenue 1Y (TTM)55.69%

Revenue growth 3Y39.7%

Revenue growth 5Y25.85%

Sales Q2Q%50.81%

3.2 Future

The Earnings Per Share is expected to grow by 100.00% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 37.95% on average over the next years. This is a very strong growth

EPS Next Y200%

EPS Next 2Y144.95%

EPS Next 3Y100%

EPS Next 5YN/A

Revenue Next Year50%

Revenue Next 2Y41.42%

Revenue Next 3Y37.95%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALENO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

With a Price/Forward Earnings ratio of 9.66, the valuation of ALENO can be described as very reasonable.

Compared to the rest of the industry, the Price/Forward Earnings ratio of ALENO indicates a rather cheap valuation: ALENO is cheaper than 85.29% of the companies listed in the same industry.

Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, ALENO is valued rather cheaply.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	9.66

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as ALENO's earnings are expected to grow with 100.00% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y144.95%

EPS Next 3Y100%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALENO!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ENOGIA SAS

EPA:ALENO (11/28/2025, 7:00:00 PM)

3.98

-0.03 (-0.75%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners6.52%

Inst Owner ChangeN/A

Ins Owners22.47%

Ins Owner ChangeN/A

Market Cap25.03M

Revenue(TTM)9.85M

Net Income(TTM)-419.00K

Analysts86.67

Price Target5.61 (40.95%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	9.66
P/S	2.54
P/FCF	N/A
P/OCF	N/A
P/B	3.34
P/tB	37.76
EV/EBITDA	N/A

EPS(TTM)-0.07

EYN/A

EPS(NY)0.41

Fwd EY10.35%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS1.57

BVpS1.19

TBVpS0.11

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.98%
ROE	-5.59%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	114.85%
FCFM	N/A

ROA(3y)-15.16%

ROA(5y)-16.28%

ROE(3y)-43.3%

ROE(5y)-107.28%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.11%

GM growth 5Y-12.18%

F-ScoreN/A

Asset Turnover0.46

Health

		Industry Rank	Sector Rank
Debt/Equity	0.8
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.82
Quick Ratio	1.8
Altman-Z	1.54

F-ScoreN/A

WACC7.88%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)59.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%107.01%

EPS Next Y200%

EPS Next 2Y144.95%

EPS Next 3Y100%

EPS Next 5YN/A

Revenue 1Y (TTM)55.69%

Revenue growth 3Y39.7%

Revenue growth 5Y25.85%

Sales Q2Q%50.81%

Revenue Next Year50%

Revenue Next 2Y41.42%

Revenue Next 3Y37.95%

Revenue Next 5YN/A

EBIT growth 1Y20.31%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year300%

EBIT Next 3Y91.29%

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

ENOGIA SAS / ALENO.PA FAQ

What is the fundamental rating for ALENO stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALENO.PA.

Can you provide the valuation status for ENOGIA SAS?

ChartMill assigns a valuation rating of 4 / 10 to ENOGIA SAS (ALENO.PA). This can be considered as Fairly Valued.

What is the profitability of ALENO stock?

ENOGIA SAS (ALENO.PA) has a profitability rating of 1 / 10.

What is the financial health of ENOGIA SAS (ALENO.PA) stock?

The financial health rating of ENOGIA SAS (ALENO.PA) is 3 / 10.

ENOGIA SAS (ALENO.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ENOGIA SAS / ALENO.PA FAQ

What is the fundamental rating for ALENO stock?

Can you provide the valuation status for ENOGIA SAS?

What is the profitability of ALENO stock?

What is the financial health of ENOGIA SAS (ALENO.PA) stock?